Payer+Provider's Health System Review
May 11, 2020
The treatment may reduce the risk to healthcare workers because it reduces the duration and quantity of viral shedding.
Despite his high profile and the deep pockets of its investors, the Amazon, Berkshire Hathaway, JP Morgan Chase joint venture has so far shown limited progress on its aspirational tech-driven healthcare goals.
Recent data breaches in digital health platforms have raised awareness for privacy protection and questions over who is responsible.
May 9, 2020
Gilead Sciences committed to supplying approximately 607,000 vials over the next six weeks to treat an estimated 78,000 hospitalized patients.
May 8, 2020
One promising candidate is remdesivir, a drug originally developed for Ebola, which the FDA has approved for emergency use during the pandemic.
Insurers get a one week extension to finalize 2021 exchange plan applications, giving them time to analyze the effect of COVID-19 in setting premiums.
May 7, 2020
Patient and staff morale has improved following implementation of a personalized, virtual rounding program intended to foster connectedness.
AHIP and HFMA expect to issue voluntary billing guidance for outpatient services soon.